Clinical Trials Logo

Clinical Trial Summary

Aim: to examine the effect of an exercise intervention for preventing osteoporosis among postmenopausal women. Objectives: To examine whether mean values for Broadband Ultrasound Attenuation (BUA) using Quantitative Ultrasound (QUS) among postmenopausal women following an eight-month exercise intervention (and at 3-month follow up), will be significantly higher than those obtained pre-intervention. To examine whether mean BUA values among postmenopausal women following an eight-month exercise intervention (and at 3-month follow up) will be significantly higher than mean values obtained from participants in a control group undertaking sham exercises for an equivalent duration. To examine the feasibility of the eight-month exercise intervention for a potential larger study (larger sample size, increased number of trial arms and increased outcome measures), in terms of recruitment, adherence, perceptions, barriers, and acceptability.


Clinical Trial Description

Data will be collected at baseline, on study completion and at 3-month follow-up. Sequel to baseline data collection and ascertainment of eligibility, participants will be randomised into either the exercise intervention group or sham-control group. Randomisation will be through computer-generation of random numbers. Participants will be blinded to group allocation. Both groups will complete their required programme for eight months. For the intervention group, participants will be required to perform 10 maximal vertical jumps, with a 10-s rest interval between each jump, using an arm swing in countermovement style on three days per week. The jumps will be performed without shoes on a hard surface. The jumps will be preceded by a warm-up lasting approximately 3 min and consisting of mobilisation exercises for the legs and lower back. Jumping will be progressed over time and in accordance with individual needs. Initially, jumping may be undertaken with the use of a handheld support (such as the back of a chair or table), should participants feel unstable. Jumps will be progressed to include multi-directional movements (jumping to the side, forwards, backwards, and diagonally). Natural progression will also occur as participants should improve their jump height with increased muscular explosiveness. Participants will be asked to fill out a simple, daily training log, stipulating when they have undertaken the exercise, in order for adherence to be assessed. In the control group, participants will be required to perform balance exercises. The balancing exercises will be progressed and varied (to ensure adherence). Initially, the use of a handheld support (such as the back of the chair) can be used. Participants will be required to balance on one leg for up to 60 seconds (2 x 60 s is equivalent in duration to the 10 jumps). This exercise will initially be progressed using time, and then by doing the following: confounding the visual fixation (e.g., head turns), changing the centre of mass (e.g. arm/leg lifts); performing the stork balance (hands on hips, knee bent and supported by standing leg); reaching in multiple directions before regaining the initial stance; closing the eyes; reducing the base of support; and a combination of these activities. The starting level of difficulty will be prescribed by the researcher, according to each participant's functional ability. The balance exercises will be preceded by a warm-up lasting approximately 3 min and consisting of mobilisation exercises for the legs and lower back. The purpose of the sham exercise is to foster the perception of full participation in the study, in order to decrease attrition rates, and to blind participants to the intervention. The balance exercises, although not improving bone health, could decrease the risk of fracture, making the sham control group more ethical, owing to potential improvements, and limited risks. To ensure quality control, digitised video clips of all exercises will be provided for the participants, who will be encouraged to perform the exercises as demonstrated on the video. The participants will be invited to one fully supervised group exercise session per month. These sessions will be used to monitor exercise quality, and to ensure progression is appropriate for each participant. Sessions will last 15-20 min. Attendance at these sessions will be monitored through registers. Apart from these supervised exercise sessions, participants will be given free choice to determine where and when they do the exercises. At the instructor-led session, training logs will be submitted. If they are unable to attend, participants will be asked to submit training logs electronically, or via post. To encourage adherence, an App will be used, which will enable weekly announcements to be posted, as well as emails and/or text reminders. Participants will be free to contact the researchers about any concerns they have during the intervention. Apart from the exercise undertaken, participants will be requested to maintain their usual exercise throughout the study. To improve adherence, Bandura's Social Cognitive Theory for changing behaviour will be drawn upon. Specific constructs will include the knowledge and skills to perform the prescribed intervention, personal regulation of goal-directed health behaviour (self-control), and self-confidence in engaging in the exercise despite the absence of supervision. Reinforcement, i.e., activities that increase the propensity for adherence during the trial and beyond the study's lifespan, will also be addressed. Participants' level of self-efficacy for engaging in lifestyle change will be assessed using a five-point Likert scale, from 'not at all confident' to 'very confident'. Participants will be asked to rate how confident they are to commit to engage in the exercise, irrespective of usual circumstances such as time constraints, stress, and fatigue. Assessment of self-efficacy will take place at the study onset, and at one-monthly intervals (via attendance at the supervised group sessions). With non-attendance, assessment will take place electronically. In the event of a low rating, modes of handling such situations without compromising commitment to the regime, will be given in relation to each participant's personal circumstances. In addition, at the study outset, participants will be asked to identify any circumstances that could motivate them to comply with the exercise, as well as any perceived barriers to adherence. Any issues will be discussed, and participants will be given the opportunity to design personalised adherence strategies. The aim will be to foster self-efficacy in both groups. After the eight-month intervention, all females in the trial arm, who have completed the study, will be invited to take part in a focus group (in groups of 8, depending on numbers who volunteer for this), to examine participants' perceptions of the intervention. A topic guide will be used, which includes: An exploration of the perceived barriers to undertaking the exercise intervention; issues with adherence; acceptability of the intervention; adverse events; enjoyment; ratings of perceived exertion; how easily the intervention could be incorporated into lifestyle. At the end of the focus group, the topic guide will be checked to ensure that all areas had been covered. Focus groups will likely last between 45 and 60 min, although will continue until the researcher feels that data saturation has been reached. The focus groups will be audio-recorded and subsequently transcribed to facilitate analysis. Non-verbal participant behaviour will also be recorded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04469374
Study type Interventional
Source Staffordshire University
Contact
Status Terminated
Phase N/A
Start date December 1, 2019
Completion date December 20, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03931109 - Circulating miRNA in Primary Hyperparathyroidism
Not yet recruiting NCT03232476 - Effect of Mechanical Loading With PTH on Cortical Bone Phase 4
Completed NCT02884401 - Peri-implant Bone Changes in Post-menopausal Osteoporotic Women N/A
Completed NCT00073190 - Patient- and Physician-Based Osteoporosis Education Phase 1
Completed NCT00402441 - Risedronate in the Prevention of Osteoporosis in Postmenopausal Women Phase 4
Completed NCT03710889 - Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption Phase 3
Completed NCT00010712 - Effects of Black Cohosh on Menopausal Hot Flashes Phase 2
Recruiting NCT05058976 - Romosozumab Use to Build Skeletal Integrity Phase 4
Active, not recruiting NCT05405894 - Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Recruiting NCT03337971 - Nutritional Supplement and Bone Health in Post-Menopausal Women N/A
Completed NCT03701113 - Milk Protein and Bone Health in Postmenopausal Women N/A
Completed NCT01381588 - The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women N/A
Completed NCT00383422 - Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis Phase 3
Completed NCT00549965 - Satisfaction and Compliance of Risedronate in PMO Phase 4
Completed NCT00035256 - Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis Phase 4
Completed NCT01386281 - Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
Completed NCT05266261 - Use of Ibandronate in Diabetic Patients N/A
Recruiting NCT04964388 - Effect of GLP-1 Receptor Agonists on Trabecular Bone Score Phase 2
Active, not recruiting NCT03623633 - Comparative Antiresorptive Efficacy Discontinuation of Denosumab Phase 4
Recruiting NCT05575167 - Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)